BioTalk

Psychedelics have been under investigation by academics, clinicians and pharmaceutical companies for some time and the momentum and...

To add to all the chatter about AI, let’s talk about AI as a medical device. Last month, the Medicines & Healthcare products Regulatory...

While it might be challenging for manufacturers of medical devices to navigate the evolving regulations of medical devices in Great...

Following the coming into force of the Windsor Agreement on 25 March 2023, we take a look at what this means in practice for the UK...

As part of last week’s Spring Budget, the UK Chancellor, Jeremy Hunt, announced increased funding of £10 million for the Medicines and...

Eighth Edition, Edited by Sally Shorthose   The Guide to EU and UK Pharmaceutical Regulatory Law is a unique volume that provides...

The UK Supreme Court has just confirmed that it will hear the appeal in FibroGen Inc v Akebia Therapeutics concerning patents for...